Tirzepatide is active from the first weekly shot, but it builds up over time: the label says blood levels reach steady state after 4 weeks of once-weekly dosing. The label does not give a day count for when appetite changes, so any "day 3" claim is a guess. The first 4 weeks are spent on the 2.5 mg starting dose, and the big trial results were measured at 72 weeks. Start with our tirzepatide guide if you are new to the drug.
Key takeaways
- Tirzepatide has an elimination half-life of about 5 days, which is why it is given once a week and why each dose reaches steady state after about 4 weeks.
- The label starts every adult at 2.5 mg once weekly for 4 weeks, then raises the dose in 2.5 mg steps no sooner than every 4 weeks, up to 15 mg.
- In SURMOUNT-1, mean weight change at 72 weeks was -15.0% at 5 mg, -19.5% at 10 mg and -20.9% at 15 mg, versus -3.1% on placebo.
- Our verified sources do not report a 4-week or 12-week weight figure, so this page does not print one.
- The most common side effects are gastrointestinal and cluster during dose escalation, so the early weeks can feel different from the later ones.
How long does it take for tirzepatide to start working?
Here is what the label actually says. After a single injection, tirzepatide stays in the body for a long time because its half-life is about 5 days. When you inject once a week, each new dose lands before the last one is gone, so the amount in your blood climbs for a few weeks and then levels off. The label puts that leveling-off point, called steady state, at about 4 weeks of once-weekly dosing.
That means the drug is doing something from week 1, but the full effect of any given dose is not reached until you have been on that dose for about a month. This is also why the label waits at least 4 weeks before each dose increase: the prescriber needs to see how you do on the full effect of the current dose before going higher.
What the label does not say is how many days it takes to notice less hunger. That varies from person to person, and the prescribing information does not report it. If you feel nothing in the first two weeks, that is not a sign the drug is failing. The starting dose is meant to let your body adjust, not to produce maximum weight loss.
Tirzepatide timeline: the label's dose schedule
The table below is the fastest schedule the label allows. Your prescriber may hold a dose longer if side effects need time to settle, and not everyone goes to 15 mg. The Zepbound label calls 2.5 mg a starting dose, not a maintenance dose, and lists 5, 10 and 15 mg as maintenance doses.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →| Weeks on treatment (earliest) | Dose | What is happening |
|---|---|---|
| Weeks 1 to 4 | 2.5 mg once weekly | Starting dose; blood level climbs toward steady state |
| Weeks 5 to 8 | 5 mg once weekly | First maintenance dose (Zepbound); new steady state after about 4 weeks |
| Weeks 9 to 12 | 7.5 mg once weekly | Optional step; prescriber decides whether to go higher |
| Weeks 13 to 16 | 10 mg once weekly | Maintenance dose |
| Weeks 17 to 20 | 12.5 mg once weekly | Optional step |
| Week 21 onward | 15 mg once weekly | Maximum dose |
Source: Zepbound and Mounjaro prescribing information (DailyMed), dosage and administration; the week numbers are arithmetic from the label's "at least 4 weeks per step" rule, not a measured timeline.
Notice what this schedule implies. Even on the fastest path the label allows, you do not even reach 15 mg until week 21, and you do not reach steady state on 15 mg until about week 25. Someone who compares their 6-week result to a 72-week trial number is comparing a starting dose to a finished course. Our tirzepatide dosage chart shows each step in detail.
Tirzepatide weight loss results at 3 months and beyond
People often search for "tirzepatide weight loss results 3 months". We can tell you what the trials measured, and we can tell you that a 12-week number is not in the publications we cite. SURMOUNT-1 reported its main results at 72 weeks. On the label's schedule, 12 weeks is only the end of the 7.5 mg step at the earliest, so a 3-month result is an early, low-dose result by definition.
| Trial and population | Length | Tirzepatide result | Placebo or comparator |
|---|---|---|---|
| SURMOUNT-1, obesity or overweight, no diabetes | 72 weeks | -15.0% (5 mg), -19.5% (10 mg), -20.9% (15 mg) | -3.1% |
| SURMOUNT-2, obesity with type 2 diabetes | 72 weeks | -12.8% (10 mg), -14.7% (15 mg) | -3.2% |
| SURMOUNT-3, after a 12-week lifestyle lead-in | 72 more weeks | -18.4% additional | +2.5% |
| SURMOUNT-4, after 36 weeks on tirzepatide (-20.9%) | 52 more weeks | -5.5% more if continued | +14.0% regain if switched to placebo |
| SURMOUNT-5, vs semaglutide, no diabetes | 72 weeks | -20.2% | -13.7% (semaglutide) |
Source: PubMed entries for SURMOUNT-1 (35658024), SURMOUNT-2 (37385275), SURMOUNT-3 (37840095), SURMOUNT-4 (38078870) and SURMOUNT-5 (40353578).
Two things in that table matter for timing. First, results scale with dose, so the pace picks up as you move through the schedule. Second, SURMOUNT-4 shows the effect is not permanent: people who stopped after 36 weeks regained 14.0% over the next year, while those who continued lost a further 5.5%. Tirzepatide works while you take it.
What changes how quickly tirzepatide works for you
- Dose. SURMOUNT-1 and SURMOUNT-2 both show more weight loss at higher doses. The early weeks at 2.5 mg are the slowest part of the course.
- Diabetes. Adults with type 2 diabetes in SURMOUNT-2 lost less on the same doses (-14.7% at 15 mg) than adults without diabetes in SURMOUNT-1 (-20.9%).
- Diet and activity. Both trials used tirzepatide alongside diet and exercise. The label describes the drug as an adjunct to a reduced-calorie diet and increased physical activity, not a replacement for them.
- Side effects. Nausea, diarrhea, vomiting and constipation were the most common adverse events in SURMOUNT-1, mostly mild to moderate and mostly during dose escalation. If they slow your escalation, your timeline stretches.
- Missed doses. The label allows a missed dose to be taken within 4 days; after that, skip it and take the next one on the regular day. Every skipped week is a week your blood level drifts down.
What this means for compounded tirzepatide
Compounded tirzepatide follows the same dosing logic because the molecule is the same, but no trial has timed a compounded product, so the numbers above describe the branded injectable only. At FormBlends, an independent clinician of Recess MD LLC sets your dose and your escalation pace; the price is $149 for the first month and $239 a month after that at any dose, so moving up a step does not cost more. See pricing or begin the assessment. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro.
Frequently Asked Questions
How long does it take for Zepbound to suppress appetite?
The Zepbound label does not give a number of days. It does say each dose reaches steady state after about 4 weeks of weekly injections, so the full effect of your current dose takes about a month to arrive. Some people notice appetite changes sooner, but the label does not measure that.
When does tirzepatide kick in?
It is in your blood after the first injection and builds for about 4 weeks. Because the first 4 weeks are at the 2.5 mg starting dose, the early effect is milder than what you will feel at a maintenance dose of 5, 10 or 15 mg.
How long does it take to lose weight on tirzepatide?
The published trials measured weight at 72 weeks, where the mean change was -15.0% to -20.9% depending on dose in SURMOUNT-1. Weight loss happens along the way, but the sources we cite do not give month-by-month figures, so we do not print them.
What are typical tirzepatide results at 3 months?
None of the publications we cite report a 12-week weight figure, so we cannot give one. At 12 weeks on the label's fastest schedule you have just finished the 7.5 mg step, so a 3-month result reflects starting and early doses, not the maintenance dose most trial results describe.
How quickly does Zepbound start working compared with Mounjaro?
They are the same molecule, tirzepatide, with the same 5-day half-life, the same 2.5 mg start and the same 4-week steps. The labels differ in what they are approved for (weight management and sleep apnea for Zepbound, type 2 diabetes for Mounjaro), not in how fast the drug acts.
Sources
- Zepbound prescribing information, DailyMed, revised 08/2026.
- Mounjaro prescribing information, DailyMed, revised 08/2026.
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), Jastreboff et al., New England Journal of Medicine, 2022.
- Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2), Garvey et al., Lancet, 2023.
- Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3), Wadden et al., Nature Medicine, 2023.
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4), Aronne et al., JAMA, 2024.
- Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5), Aronne et al., New England Journal of Medicine, 2025.
Next steps
See what the first weeks feel like in what to expect your first week on tirzepatide, then check how much weight you can lose on tirzepatide. Browse the tirzepatide hub for every other tirzepatide question. Talk to a licensed clinician before starting or changing any medication. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →